This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/7/2024
Mohit Bansal
Biotech and Pharma Analyst, Wells Fargo
Great. Thank you very much for joining us today. My name is Mohit Bansal. I'm one of the biotech and pharma analysts here at Wells Fargo, and I'm joined by Tim Ironwood today. So we have Tom McCourt, the CEO of the company, and we have Shravan Imani, the CFO of the company. Thank you very much for joining us.
Tom McCourt
CEO
Great to be here.
Mohit Bansal
Biotech and Pharma Analyst, Wells Fargo
Great. So maybe let's just start with those who are new to the story. They are trying to learn the story. Talk a little bit about the company, just a brief overview of the company and what you're up to.
You're reading a preview of the IRWD Q3 2024 earnings call.
Free account.
Disclaimer